Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inotiv, Inc. Director's Dealing 2021

Mar 1, 2021

34595_dirs_2021-03-01_6ec39ca3-e4a7-49f3-b76b-603dd2c1be7a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2021-03-01

Reporting Person: Beattie John Gregory (Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-03-01 Common Shares P 1712 $18.60 Acquired 25000 Direct